1. Home
  2. BOLD vs WVVI Comparison

BOLD vs WVVI Comparison

Compare BOLD & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • WVVI
  • Stock Information
  • Founded
  • BOLD 2018
  • WVVI 1983
  • Country
  • BOLD United States
  • WVVI United States
  • Employees
  • BOLD N/A
  • WVVI N/A
  • Industry
  • BOLD
  • WVVI Beverages (Production/Distribution)
  • Sector
  • BOLD
  • WVVI Consumer Staples
  • Exchange
  • BOLD Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • BOLD 30.3M
  • WVVI 28.2M
  • IPO Year
  • BOLD 2024
  • WVVI N/A
  • Fundamental
  • Price
  • BOLD $1.09
  • WVVI $5.60
  • Analyst Decision
  • BOLD Buy
  • WVVI
  • Analyst Count
  • BOLD 3
  • WVVI 0
  • Target Price
  • BOLD $4.00
  • WVVI N/A
  • AVG Volume (30 Days)
  • BOLD 367.5K
  • WVVI 25.0K
  • Earning Date
  • BOLD 08-11-2025
  • WVVI 08-12-2025
  • Dividend Yield
  • BOLD N/A
  • WVVI N/A
  • EPS Growth
  • BOLD N/A
  • WVVI N/A
  • EPS
  • BOLD N/A
  • WVVI N/A
  • Revenue
  • BOLD N/A
  • WVVI $38,520,945.00
  • Revenue This Year
  • BOLD N/A
  • WVVI N/A
  • Revenue Next Year
  • BOLD N/A
  • WVVI N/A
  • P/E Ratio
  • BOLD N/A
  • WVVI N/A
  • Revenue Growth
  • BOLD N/A
  • WVVI N/A
  • 52 Week Low
  • BOLD $1.00
  • WVVI $3.17
  • 52 Week High
  • BOLD $4.72
  • WVVI $7.18
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • WVVI 50.10
  • Support Level
  • BOLD N/A
  • WVVI $5.50
  • Resistance Level
  • BOLD N/A
  • WVVI $5.89
  • Average True Range (ATR)
  • BOLD 0.00
  • WVVI 0.53
  • MACD
  • BOLD 0.00
  • WVVI 0.04
  • Stochastic Oscillator
  • BOLD 0.00
  • WVVI 41.04

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: